Type

Other / n/a

Authors

Raymond L Stallings
Maureen O'Sullivan
Anne O'Meara
Jacqueline Ryan
Patrick G Buckley
Derek M Murphy
Kenneth Bryan
Amanda Tivnan
Isabella Bray
Niamh H Foley

Subjects

Biochemistry

Topics
cell line neoplastic medicine and health sciences reverse transcriptase polymerase chain reaction proto oncogene proteins c akt gene expression regulation neoplastic blotting oncogene proteins blotting western nuclear proteins humans gene expression regulation cell line tumor gene expression tumor micrornas western genetics apoptosis neuroblastoma transfection

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. (2010)

Abstract BACKGROUND: Neuroblastoma is a paediatric cancer of the sympathetic nervous system. The single most important genetic indicator of poor clinical outcome is amplification of the MYCN transcription factor. One of many down-stream MYCN targets is miR-184, which is either directly or indirectly repressed by this transcription factor, possibly due to its pro-apoptotic effects when ectopically over-expressed in neuroblastoma cells. The purpose of this study was to elucidate the molecular mechanism by which miR-184 conveys pro-apoptotic effects.RESULTS: We demonstrate that the knock-down of endogenous miR-184 has the opposite effect of ectopic up-regulation, leading to enhanced neuroblastoma cell numbers. As a mechanism of how miR-184 causes apoptosis when over-expressed, and increased cell numbers when inhibited, we demonstrate direct targeting and degradation of AKT2, a major downstream effector of the phosphatidylinositol 3-kinase (PI3K) pathway, one of the most potent pro-survival pathways in cancer. The pro-apoptotic effects of miR-184 ectopic over-expression in neuroblastoma cell lines is reproduced by siRNA inhibition of AKT2, while a positive effect on cell numbers similar to that obtained by the knock-down of endogenous miR-184 can be achieved by ectopic up-regulation of AKT2. Moreover, co-transfection of miR-184 with an AKT2 expression vector lacking the miR-184 target site in the 3'UTR rescues cells from the pro-apoptotic effects of miR-184.CONCLUSIONS: MYCN contributes to tumorigenesis, in part, by repressing miR-184, leading to increased levels of AKT2, a direct target of miR-184. Thus, two important genes with positive effects on cell growth and survival, MYCN and AKT2, can be linked into a common genetic pathway through the actions of miR-184. As an inhibitor of AKT2, miR-184 could be of potential benefit in miRNA mediated therapeutics of MYCN amplified neuroblastoma and other forms of cancer.
Collections Ireland -> Royal College of Surgeons in Ireland -> Cancer Genetics Articles
Ireland -> Royal College of Surgeons in Ireland -> Department of Cancer Genetics

Full list of authors on original publication

Raymond L Stallings, Maureen O'Sullivan, Anne O'Meara, Jacqueline Ryan, Patrick G Buckley, Derek M Murphy, Kenneth Bryan, Amanda Tivnan, Isabella Bray, Niamh H Foley

Experts in our system

1
Raymond L Stallings
Royal College of Surgeons in Ireland
Total Publications: 59
 
2
Kenneth Bryan
Royal College of Surgeons in Ireland
Total Publications: 36
 
3
Amanda Tivnan
Royal College of Surgeons in Ireland
Total Publications: 15
 
4
Isabella Bray
Royal College of Surgeons in Ireland
Total Publications: 35